As predicted, the estimates of CMRglc declined with disease duration, indicating the natural progression of the disease in this group of patients, signifying the conclusion that GLP-1 receptor stimulation halts the progression of Alzheimer’s disease, in association with a very significant increase of the Tmax estimates. Here, GLP1R is linked to early-onset autosomal dominant Alzheimer disease.